Cannell & Spears’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,105
Closed -$295K 180
2018
Q3
$295K Hold
3,105
0.04% 139
2018
Q2
$240K Hold
3,105
0.03% 153
2018
Q1
$214K Hold
3,105
0.03% 159
2017
Q4
$232K Sell
3,105
-140
-4% -$8.95K 0.03% 159
2017
Q3
$205K Sell
3,245
-100
-3% -$6.21K 0.02% 146
2017
Q2
$214K Hold
3,345
0.03% 140
2017
Q1
$220K Sell
3,345
-100
-3% -$6.88K 0.03% 121
2016
Q4
$237K Buy
3,445
+100
+3% +$7.17K 0.03% 118
2016
Q3
$236K Hold
3,345
0.03% 114
2016
Q2
$254K Hold
3,345
0.03% 105
2016
Q1
$230K Hold
3,345
0.03% 114
2015
Q4
$292K Sell
3,345
-50
-1% -$4.28K 0.03% 102
2015
Q3
$275K Buy
+3,395
New +$296K 0.03% 113

Other funds holding ESRX

Cannell & Spears's ESRX Position: Q4 2018 in Review

Cannell & Spears sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 3,105 shares — an estimated $295K sold.

Cannell & Spears first reported a position in ESRX in Q3 2015 and held it in 13 quarters. The position peaked at $295K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Cannell & Spears reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Cannell & Spears sold 3,105 Express Scripts Holding Company shares in Q4 2018, an estimated $295K.
  • Cannell & Spears first reported a position in Express Scripts Holding Company in Q3 2015 and held it in 13 quarters.
  • Cannell & Spears's Express Scripts Holding Company position peaked at $295K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Cannell & Spears's 13F filing for Q4 2018, filed 13 Feb 2019.